NCT03183206View on ClinicalTrials.gov

Safety and Efficiency of γδ T Cell Against Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2019

Conditions
Breast Cancer
Interventions
PROCEDURE

Cryosurgery , IRE surgery ,surgery

surgery will be used in local tumor

BIOLOGICAL

γδ T cells

γδ T cells will be used against

OTHER

γδ T cells/ Surgery

Combination γδ T cell and Cryosurgery, IRE surgery or surgery will be used in Breast Cancer

Trial Locations (1)

510665

Biotherapy center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Jinan University Guangzhou

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT03183206 - Safety and Efficiency of γδ T Cell Against Breast Cancer | Biotech Hunter | Biotech Hunter